Abstract
Background
The frequency of “complicated” pleural effusions (CPE) (i.e., pleural fluid pH ≤ 7.2 and/or glucose ≤60 mg/dL) of tuberculous origin (CTPE) is not well reported. This study aims to quantify their prevalence, and develop a score to differentiate CTPE from complicated parapneumonic effusions (CPPE).
Methods
Retrospective analysis of databases from three Spanish hospitals which included patients with CTPE and CPPE. Forty percent of the study population served to generate a scoring system (COMPLES, COMplicated PLeural Effusion Score) that was further validated in the remaining 60 %.
Results
During the study period (1992–2015) 549 patients were diagnosed with tuberculous effusions and 434 parapneumonic effusions, of whom 25 and 64 %, respectively, had CPE. COMPLES was based on the combination of pleural fluid adenosine deaminase (ADA), the percentage of mononuclear cells (MNC %), pH, and age. The cutoff values and assigned scores were: ADA (<46 IU/L [0 points], 46–100 IU/L [4 points], ≥100 IU/L [6 points]), MNC % (<10 % [0 points], 10–50 [3 points], >50 [8 points]), pH (<7.07 [0 points], 7.07–7.20 [3 points], >7.20 [5 points]), and age (≥30 [0 points], <30 years [3 points]). A sum of 12 or more points had 97 % sensitivity, 92 % specificity, likelihood ratio positive 12.3, likelihood ratio negative 0.03, and area under the curve of 0.947 for identifying CTPE versus CPPE in the validation set.
Conclusions
CPE is not an unusual presentation of tuberculosis. A simple new scoring system provides a reliable tool for differentiating between CTPE and CPPE.
Similar content being viewed by others
Abbreviations
- ADA:
-
Adenosine deaminase
- AUC:
-
Area under curve
- CI:
-
Confidence interval
- COMPLES:
-
Complicated pleural effusion score
- CPE:
-
Complicated pleural effusion
- CPPE:
-
Complicated parapneumonic pleural effusion
- CTPE:
-
Complicated tuberculous pleural effusion
- IFN:
-
Interferon
- LDH:
-
Lactate dehydrogenase
- LR:
-
Likelihood ratio
- MNC %:
-
Percentage of mononuclear cells
- NAAT:
-
Nucleic acid amplification test
- NCTPE:
-
Noncomplicated tuberculous pleural effusion
- ROC:
-
Receiving operating characteristics
- TPE:
-
Tuberculous pleural effusion
References
Valdes L, Alvarez D, Valle JM, Pose A, San JE (1996) The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 109:158–162
Porcel JM, Esquerda A, Vives M, Bielsa S (2014) Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 2014:161–165
Sahn SA, Huggins JT, San Jose ME, varez-Dobano JM, Valdes L (2013) Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone? Int J Tuberc Lung Dis 2013:787–793
Porcel JM, Palma R, Valdes L, Bielsa S, San-Jose E, Esquerda A (2013) Xpert(R) MTB/RIF in pleural fluid for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2013:1217–1219
Lin CM, Lin SM, Chung FT, Lin HC, Lee KY, Huang CD, Kuo CH, Liu CY, Wang CH, Kuo HP (2012) Amplified Mycobacterium tuberculosis direct test for diagnosing tuberculous pleurisy—a diagnostic accuracy study. PLoS ONE 2012:e44842
Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ (2008) Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 102:744–754
Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C (2003) Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 7:777–786
Goto M, Noguchi Y, Koyama H, Hira K, Shimbo T, Fukui T (2003) Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis. Ann Clin Biochem 40:4–81
Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ (2007) Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 131:1133–1141
Lin MT, Wang JY, Yu CJ, Lee LN, Yang PC (2009) Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers. Respir Med 103:820–826
Hirsch A, Ruffie P, Nebut M, Bignon J, Chretien J (1979) Pleural effusion: laboratory tests in 300 cases. Thorax 34:106–112
Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD (2000) Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 118:1158–1171
Davies HE, Davies RJ, Davies CW (2010) Management of pleural infection in adults: Br Thorac Soc Pleural Dis Guideline. Thorax 65:Suppl-53
Jolobe OM (2001) Atypical tuberculous pleural effusions. Eur J Intern Med 22:456–459
Porcel JM (2011) Pearls and myths in pleural fluid analysis. Respirology 2011:44–52
Krenke R, Safianowska A, Paplinska M, Nasilowski J, Dmowska-Sobstyl B, Bogacka-Zatorska E, Jaworski A, Chazan R (2008) Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy. J Physiol Pharmacol 59:Suppl-60
Porcel JM (2009) Tuberculous pleural effusion. Lung 187:263–270
Burgess LJ, Maritz FJ, Le R, Taljaard JJ (1996) Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest 109:414–419
DeOliveria HG, Rossatto ER, Prolla JC (1994) Pleural fluid adenosine deaminase and lymphochyte proportion: clinical uselfulness in the diagnosis of tuberculosis. Cytopathology 5:27–32
Garcia-Zamalloa A, Taboada-Gomez J (2012) Diagnostic accuracy of Adenosine deaminase and lymphocyte proportion in pleural fluid for Tuberculous pleurisy in different prevalence scenarios. PLoS ONE 7:e38729
Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW (2001) Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 120:356–361
Porcel JM, Vives M (2002) Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 121:1379–1380
Jimenez CD, Diaz NG, Perez-Rodriguez E, Light RW (2003) Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 21:220–224
Burgess LJ, Maritz FJ, Le R, Taljaard JJ (1995) Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax 50:672–674
Valdes L, San JE, varez Dobano JM, Golpe A, Valle JM, Penela P, Gonzalez Barcala FJ (2009) Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions. Eur Respir J 33:816–820
Chang HK, Eun KM, Sung HP, Yong IH, Seung HJ, Yong BP, Cheol HK, Kim D-G, Myung GL, In GH, Jung K-S (2009) Usefulness of the pleural fluid adenosine deaminase with lymphocyte/neutrophil ratio in the diagnosis of tuberculous pleurisy for a region of intermediate prevalence of tuberculosis. Tuberc Respir Dis 66:437–443
Villena V, Lopez EA, Echave-Sustaeta J, Alvarez MC, Martin EP (2002) Prospective study of 1,000 consecutive patients with pleural effusion. Etiology of the effusion and characteristics of the patients. Arch Bronconeumol 38:21–26
World Health Organization (2016) Tuberculosis country profiles, 2015. http://www.who.int/tb/country/data/profiles/en/. Accessed 24 March 2016
Working group for multicenter research project on tuberculosis (PMIT) (1999) Tuberculosis in Spain: PMIT results. Instituto de Salud Carlos III, Madrid
Acknowledgments
The authors thank Mr. Ramiro González for his assistance with the microbiological database in the Ponferrada cohort.
Authors’ Contributions
L.C-G: Development of the study concept and study design, analysis and interpretation of data, statistical analysis, study selection for systematic review, extract data from studies and metaanalysis, drafting the manuscript, generating figures, and final approval of manuscript. C.P-G, D.A, PR.D-S-G: Acquisition of clinical data (Ponferrada), study selection for systematic review, discussing the content and figures, revising the draft, and final approval of manuscript. J.M.P, S.B: Development of study design, acquisition of clinical data (Lleida), analysis and interpretation of data, discussing the content and figures, revising the draft, and final approval of manuscript. A.G-Z, J.T-G: Development of study design, acquisition of clinical data (Mendaro), analysis and interpretation of data, discussing the content and figures, revising the draft, and final approval of manuscript. MA.A-F: Development of the study concept, discussing the content and figures, revising the draft, and final approval of manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Corral-Gudino, L., García-Zamalloa, A., Prada-González, C. et al. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions. Lung 194, 847–854 (2016). https://doi.org/10.1007/s00408-016-9923-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-016-9923-y